| 1 |
26666965 | Inhibition of macrophage-derived foam cell formation by ezetimibe via the caveolin-1/MAPK pathway. | 2016 Feb |
2 |
| 2 |
27798147 | NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice. | 2016 Nov 15 |
1 |
| 3 |
23119157 | Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and α(v)β(3) Integrin. | 2012 |
1 |
| 4 |
21044018 | New concept of vascular calcification and metabolism. | 2011 Jan |
1 |
| 5 |
18479686 | Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. | 2009 Jan |
2 |
| 6 |
18603252 | Vascular protective effects of ezetimibe in ApoE-deficient mice. | 2009 Mar |
3 |
| 7 |
18585981 | Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1). | 2008 Sep |
2 |
| 8 |
18706289 | Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis. | 2008 Mar-Apr |
1 |
| 9 |
17218600 | Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice. | 2007 Apr |
1 |
| 10 |
11742881 | Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. | 2001 Dec |
4 |